These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8398031)

  • 1. Pharmacokinetic considerations in critical care.
    Reynolds JR
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):227-35. PubMed ID: 8398031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A primer on pharmacokinetics.
    Quan DJ
    Nephrol Nurs J; 2008; 35(2):213-5. PubMed ID: 18472692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic changes in critical illness.
    Boucher BA; Wood GC; Swanson JM
    Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic monitoring of the elderly in critical care.
    Planchock NY; Slay LE
    Crit Care Nurs Clin North Am; 1996 Mar; 8(1):79-89. PubMed ID: 8695038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic aspects of pediatric drug therapy].
    Pokrajac M
    Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():22-6. PubMed ID: 18193797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic considerations in critical care of the elderly.
    Nielson C
    Clin Geriatr Med; 1994 Feb; 10(1):71-89. PubMed ID: 8168028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
    Messina S; Battino D; Croci D; Mamoli D; Ratti S; Perucca E
    Epilepsia; 2005 Mar; 46(3):372-7. PubMed ID: 15730534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
    DeVane CL; Gill HS
    J Clin Psychiatry; 1997; 58 Suppl 5():7-14. PubMed ID: 9184622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug dosing in continuous renal replacement therapy: general rules.
    Schetz M
    Curr Opin Crit Care; 2007 Dec; 13(6):645-51. PubMed ID: 17975384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations.
    Papadopoulos J; Smithburger PL
    Crit Care Med; 2010 Jun; 38(6 Suppl):S126-35. PubMed ID: 20502166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accounting for pharmacokinetic and pharmacodynamic variability: ten factors to consider before prescribing.
    O'Malley P
    Clin Nurse Spec; 2007; 21(6):274-5. PubMed ID: 18000438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV protease inhibitors: pharmacologic and metabolic distinctions.
    Sommadossi JP
    AIDS; 1999 Sep; 13 Suppl 1():S29-40. PubMed ID: 10546783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial dosing considerations in obese adult patients.
    Pai MP; Bearden DT
    Pharmacotherapy; 2007 Aug; 27(8):1081-91. PubMed ID: 17655508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current state of knowledge on age, sex, and their interactions on clinical pharmacology.
    Schwartz JB
    Clin Pharmacol Ther; 2007 Jul; 82(1):87-96. PubMed ID: 17495875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics.
    Pichini S; Papaseit E; Joya X; Vall O; Farré M; Garcia-Algar O; de laTorre R
    Ther Drug Monit; 2009 Jun; 31(3):283-318. PubMed ID: 19363463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interactions and antipsychotic therapy.
    DeVane CL
    Pharmacotherapy; 1996; 16(1 Pt 2):15-20. PubMed ID: 8778682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.